Old age, high risk medication, polypharmacy: a ‘trilogy’ of risks in older patients with atrial fibrillation

BACKGROUND: The safety of pharmacotherapy in atrial fibrillation (AF) is compounded by a trilogy of risks old age, high-risk medications (e.g., antithrombotics, antiarrhythmics), polypharmacy due to multiple patient comorbidities. However, to date, scarce study has investigated the use of polypharma...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang., Yishen, Singh., Shamsher, Bajorek., Beata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930859/
https://www.ncbi.nlm.nih.gov/pubmed/27382425
http://dx.doi.org/10.18549/PharmPract.2016.02.706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930859/
https://www.ncbi.nlm.nih.gov/pubmed/27382425
http://dx.doi.org/10.18549/PharmPract.2016.02.706

Ejemplares similares